PD Dr. Daniela Schmidt



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

VEXAS syndrome mimicking lupus-like disease (2023) Valor-Mendez L, Sticherling M, Zeschick M, Atreya R, Schmidt D, Waldfahrer F, Saake M, et al. Journal article, Letter Beta-HCG elevation as first sign of a malignant somatic transformation of a non-seminomatous germ cell tumor (2021) Peuser M, Hartmann A, Schmidt D, Mackensen A, Meidenbauer N Conference contribution Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study (2021) Schönau V, Roth J, Tascilar K, Corte G, Manger B, Rech J, Schmidt D, et al. Journal article Therapies for synchronous malignomas - the importance of interdisciplinary oncology (2021) Mueller SK, Haderlein M, Traxdorf M, Semrau S, Agaimy A, Lettmaier S, Gostian AO, et al. Journal article, Editorial Thrombopoietin receptor agonists for acquired thrombocytopenia following anti-CD19 CAR-T-cell therapy: A case report (2021) Jitschin R, Kharboutli S, Stoll A, Büttner-Herold M, Schmidt D, Rösler W, Mackensen A, et al. Journal article The Distribution of Pelvic Nodal Metastases in Prostate Cancer Reveals Potential to Advance and Personalize Pelvic Radiotherapy (2021) Filimonova I, Schmidt D, Mansoorian S, Weissmann T, Siavooshhaghighi H, Kuwert T, Bert C, et al. Journal article Individual Calculation of Effective Dose and Risk of Malignancy Based on Monte Carlo Simulations after Whole Body Computed Tomography (2020) Kopp M, Loewe T, Wüst W, Brand M, Wetzl M, Nitsch W, Schmidt D, et al. Journal article Successful Targeting of BRAF V600E Mutation With Vemurafenib in a Treatment-Resistant Extragonadal Nonseminomatous Germ-Cell Tumor (2020) Meintker L, Haller F, Tögel L, Schmidt D, Waibel H, Hartmann A, Mackensen A, Meidenbauer N Journal article Classification of three prognostically different groups of head and neck cancer patients based on their metabolic response to induction chemotherapy (IC-1) (2020) Semrau S, Schmidt D, Hecht M, Haderlein M, Kitzsteiner C, Müller S, Traxdorf M, et al. Journal article Single-cycle induction chemotherapy before chemoradiotherapy or surgery in functionally inoperable head and neck squamous cell carcinoma: 10-year results (2019) Breheret M, Lubgan D, Haderlein M, Hecht M, Traxdorf M, Schmidt D, Mueller SK, et al. Journal article
1 2 3